Dihydroergotamine (injection)
| Dihydroergotamine |
|---|
| MIGRANAL (dihydroergotamine mesylate) spray® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Dihydroergotamine |
| ClinicalTrials.gov |
| Dihydroergotamine |
| D.H.E. 45 (dihydroergotamine mesylate) injection, solution® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Dihydroergotamine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information about Dihydroergotamine, click here.
Synonyms / Brand Names: MIGRANAL (dihydroergotamine mesylate) spray®, D.H.E. 45®, DIHYDROERGOTAMINE MESYLATE injection®
Overview
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Pharmacokinetic data | |
| Elimination half-life | 9 hours |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C33H37N5O5 |
| Molar mass | 583.678 g/mol |
Dihydroergotamine is an ergot alkaloid used to treat migraines.
Category
FDA Package Insert
MIGRANAL (dihydroergotamine mesylate) spray Normal 0 false false false EN-US X-NONE X-NONE
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
D.H.E. 45 (dihydroergotamine mesylate) injection, solution Normal 0 false false false EN-US X-NONE X-NONE
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
Dihydroergotamine is an ergot alkaloid used to treat migraines.[1] [1] Normal 0 false false false EN-US X-NONE X-NONE
References
- Pages with script errors
- Pages with reference errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs
- Lysergamides